Compare POLY MEDICURE with Opto Circuit - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

POLY MEDICURE vs OPTO CIRCUITS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    POLY MEDICURE OPTO CIRCUITS POLY MEDICURE/
OPTO CIRCUITS
 
P/E (TTM) x 65.2 -5.1 - View Chart
P/BV x 9.9 - - View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 POLY MEDICURE   OPTO CIRCUITS
EQUITY SHARE DATA
    POLY MEDICURE
Mar-21
OPTO CIRCUITS
Mar-20
POLY MEDICURE/
OPTO CIRCUITS
5-Yr Chart
Click to enlarge
High Rs9139 9,827.8%   
Low Rs2071 14,289.7%   
Sales per share (Unadj.) Rs82.06.0 1,360.9%  
Earnings per share (Unadj.) Rs13.8-45.9 -30.1%  
Cash flow per share (Unadj.) Rs18.8-45.7 -41.1%  
Dividends per share (Unadj.) Rs2.500-  
Avg Dividend yield %0.40-  
Book value per share (Unadj.) Rs100.6-2.5 -3,978.1%  
Shares outstanding (eoy) m95.88300.63 31.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x6.80.9 766.4%   
Avg P/E ratio x40.5-0.1 -34,619.4%  
P/CF ratio (eoy) x29.8-0.1 -25,381.5%  
Price / Book Value ratio x5.6-2.1 -262.2%  
Dividend payout %18.10-   
Avg Mkt Cap Rs m53,7031,614 3,326.6%   
No. of employees `000NANA-   
Total wages/salary Rs m1,418449 315.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m7,8651,812 434.0%  
Other income Rs m18448 387.2%   
Total revenues Rs m8,0491,860 432.8%   
Gross profit Rs m2,165-13,498 -16.0%  
Depreciation Rs m47555 857.6%   
Interest Rs m106288 37.0%   
Profit before tax Rs m1,767-13,794 -12.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4422 25,686.0%   
Profit after tax Rs m1,326-13,796 -9.6%  
Gross profit margin %27.5-744.9 -3.7%  
Effective tax rate %25.00 -200,026.1%   
Net profit margin %16.9-761.4 -2.2%  
BALANCE SHEET DATA
Current assets Rs m7,4951,669 449.1%   
Current liabilities Rs m2,15110,118 21.3%   
Net working cap to sales %67.9-466.3 -14.6%  
Current ratio x3.50.2 2,112.6%  
Inventory Days Days1951,166 16.7%  
Debtors Days Days726112 646.6%  
Net fixed assets Rs m5,1799,319 55.6%   
Share capital Rs m4793,006 15.9%   
"Free" reserves Rs m9,168-3,767 -243.4%   
Net worth Rs m9,648-760 -1,268.8%   
Long term debt Rs m6331,704 37.1%   
Total assets Rs m12,67410,987 115.4%  
Interest coverage x17.6-46.9 -37.5%   
Debt to equity ratio x0.1-2.2 -2.9%  
Sales to assets ratio x0.60.2 376.3%   
Return on assets %11.3-122.9 -9.2%  
Return on equity %13.71,814.2 0.8%  
Return on capital %18.2-1,431.3 -1.3%  
Exports to sales %61.30-   
Imports to sales %26.916.8 159.8%   
Exports (fob) Rs m4,818NA-   
Imports (cif) Rs m2,116305 693.6%   
Fx inflow Rs m4,818613 786.5%   
Fx outflow Rs m2,116307 690.4%   
Net fx Rs m2,702306 882.8%   
CASH FLOW
From Operations Rs m1,187723 164.3%  
From Investments Rs m-4,356-1,495 291.3%  
From Financial Activity Rs m3,169759 417.7%  
Net Cashflow Rs m1-14 -7.1%  

Share Holding

Indian Promoters % 44.5 22.9 194.7%  
Foreign collaborators % 0.2 5.4 4.5%  
Indian inst/Mut Fund % 16.6 2.3 713.4%  
FIIs % 13.7 0.5 2,850.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 55.2 71.8 77.0%  
Shareholders   33,678 100,554 33.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare POLY MEDICURE With:   PREVEST DENPRO  RAAJ MEDISAFE  KRETTO SYSCON  SHREE PACETRONIX  KMS MEDISURGI  



Today's Market

5 Reasons Why Sensex Slumped 949 Points Today(Closing)

Indian share markets witnessed huge selling pressure today and ended deep in the red.

Related Views on News

POLY MEDICURE 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of POLY MEDICURE for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of POLY MEDICURE. Also includes updates on the valuation of POLY MEDICURE.

POLY MEDICURE Announces Quarterly Results (1QFY22); Net Profit Up 42.0% (Quarterly Result Update)

Jul 31, 2021 | Updated on Jul 31, 2021

For the quarter ended June 2021, POLY MEDICURE has posted a net profit of Rs 369 m (up 42.0% YoY). Sales on the other hand came in at Rs 2 bn (up 24.4% YoY). Read on for a complete analysis of POLY MEDICURE's quarterly results.

5 Indian Companies Embracing Blockchain Technology (Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

From Paytm to Reliance Power: Big IPOs with the Worst Debut Day Performance (Views On News)

Nov 22, 2021

Paytm's flop show should not come as a surprise. This is not the first time a high-profile IPO has eroded investors' wealth on listing day.

Top 5 Stocks in which FIIs Sequentially Raised their Stakes (Views On News)

Oct 26, 2021

FIIs have largely stayed on the sidelines this month, booking profits at every opportunity they get, amid tapering concerns.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

POLY MEDICURE SHARE PRICE


Dec 6, 2021 (Close)

TRACK POLY MEDICURE

  • Track your investment in POLY MEDICURE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

POLY MEDICURE - PREVEST DENPRO COMPARISON

COMPARE POLY MEDICURE WITH

MARKET STATS